Longitude Capital Partners IV LLC 13D and 13G filings for Vera Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-04 7:49 pm Purchase | 2024-10-31 | 13D | Vera Therapeutics, Inc. VERA | Longitude Capital Partners IV LLC | 5,184,062 8.400% | 20,000 (+0.39%) | Filing |
| 2024-02-05 4:45 pm Purchase | 2024-02-01 | 13D | Vera Therapeutics, Inc. VERA | Longitude Capital Partners IV LLC | 5,164,062 9.800% | 9,925 (+0.19%) | Filing |
| 2023-02-16 4:40 pm Purchase | 2023-02-06 | 13D | Vera Therapeutics, Inc. VERA | Longitude Capital Partners IV LLC | 5,154,137 12.300% | 1,714,285 (+49.84%) | Filing |
| 2022-04-05 07:36 am Purchase | 2022-02-10 | 13D | Vera Therapeutics, Inc. VERA | Longitude Capital Partners IV LLC | 3,439,852 12.700% | 343,258 (+11.09%) | Filing |
| 2021-05-27 4:32 pm Purchase | 2021-05-18 | 13D | Vera Therapeutics, Inc. VERA | Longitude Capital Partners IV LLC | 3,096,594 15.100% | 3,096,594 (New Position) | Filing |